Recruiting PHASE3 Idiopathic Scoliosis

New treatment option for Idiopathic Scoliosis

Official title Evaluation of Analgesia for Spine Fusion Elective Surgery in Children

ClinicalTrials.gov ID: NCT06626503

What this study is testing

What is Methadone based ERAS?

Methadone based ERAS is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for idiopathic scoliosis.

Also referred to as Methadone Based.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The multicenter PRECISE Analgesia (Prospective Randomized Evaluation of Analgesia for Idiopathic Scoliosis Spine Fusion Elective Surgery in Children) trials will a) implement and investigate the efficacy and safety of multidose methadone-based standardized enhanced recovery after surgery (ERAS) protocol, and b) develop personalized ERAS protocols including precision methadone and oxycodone dosing and c) personalized analgesia for the safe and effective opioid-sparing management of surgical pain after posterior spine fusion (PSF) in children.
  • Phase 3: a large, late-stage study
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 10 to 18

You may be able to join if

  • Age 10 - \< 18 years
  • American Society of Anesthesiologists (ASA) Physical Status 1 or 2
  • Undergoing PSF for idiopathic scoliosis
  • Participant or legal guardian can speak and read English or Spanish

You likely can't join if

  • Pregnant patients
  • Methadone allergy
  • Preoperative prolonged QTc more than 460 msec (-30 days to 0 day)
  • people undergoing concomitant treatment with known cytochrome P450 inhibitors included in methadone labeling (i.e. macrolides (e.g. erythromycin)...
  • Preoperative opioid use within 30 days before surgery
  • History of severe sleep apnea, defined as a prior sleep study demonstrating an apnea-hypopnea index (AHI) greater than 10.
See the full eligibility criteria
Who can join
  • Age 10 - \< 18 years
  • American Society of Anesthesiologists (ASA) Physical Status 1 or 2
  • Undergoing PSF for idiopathic scoliosis
  • Participant or legal guardian can speak and read English or Spanish
What rules you out
  • Pregnant patients
  • Methadone allergy
  • Preoperative prolonged QTc more than 460 msec (-30 days to 0 day)
  • people undergoing concomitant treatment with known cytochrome P450 inhibitors included in methadone labeling (i.e. macrolides (e.g. erythromycin), azole-antifungal agents (e.g. ketoconazole, voriconazole), protease...
  • Preoperative opioid use within 30 days before surgery
  • History of severe sleep apnea, defined as a prior sleep study demonstrating an apnea-hypopnea index (AHI) greater than 10.
  • Significant liver, kidney, neurological disease, developmental delay, or any other co-existing medical condition per discretion of the clinical investigator

The study team makes the final eligibility decision.

Where it's taking place

  • Cincinnati, Ohio, United States
  • Pittsburgh, Pennsylvania, United States

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 10 years to 18 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Cincinnati, Ohio, United States; Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.